Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers
Status:
Completed
Trial end date:
2019-08-06
Target enrollment:
Participant gender:
Summary
Study to assess the pharmacokinetics of plasma doravirine once daily over 72 hours following
drug intake cessation at steady-state in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Chelsea and Westminster NHS Foundation Trust
Collaborators:
Imperial College London Merck Sharp & Dohme Corp. University of Liverpool